Dose-response effect of RPE65 gene therapy on retinoid levels and correlation with clinical rescue in Rpe65-deficient dogs

被引：0
|
作者：
Mowat, Freya [1 ,2 ]
Feathers, Kecia L. [3 ]
Smith, Alexander J. [2 ,4 ]
Thompson, Debra A. [3 ]
Petersen-Jones, Simon M. [1 ]
Bainbridge, James W. B. [2 ,4 ]
Ali, Robin R. [2 ,4 ]
机构：
[1] Michigan State Univ, Coll Vet Med, Small Anim Clin Sci, E Lansing, MI 48824 USA
[2] UCL Inst Ophthalmol, London, England
[3] Univ Michigan, Dept Biol Chem, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA
[4] Biomed Res Ctr Ophthalmol Moorfields, Natl Inst Hlth Res, London, England
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2015年 / 56卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
2064
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Pre-clinical toxicology of AAV2/5-OPTIRPE65, an optimised RPE65 gene therapy vector
    Georgiadis, A.
    Duran, Y.
    Ribeiro, J.
    Abelleira, L.
    Naylor, S.
    Smith, A. J.
    Bainbridge, J. W. B.
    Ali, R. R.
    HUMAN GENE THERAPY, 2017, 28 (12) : A77 - A77
  • [42] Regulation of Retinal Function but Nonrescue of Vision in RPE65-deficient Dogs Treated With Doxycycline-regulatable AAV Vectors
    Lheriteau, Elsa
    Libeau, Lyse
    Mendes-Madeira, Alexandra
    Deschamps, Jack-Yves
    Weber, Michel
    Le Meur, Guylene
    Provost, Nathalie
    Guihal, Caroline
    Moullier, Philippe
    Rolling, Fabienne
    MOLECULAR THERAPY, 2010, 18 (06) : 1085 - 1093
  • [43] Clinical Trial of Gene Therapy for Early Onset Severe Retinal Dystrophy Resulting from Defects in RPE65
    Ali, Robin R.
    Bainbridge, J. W. B.
    Smith, A. J.
    Fitzke, F. W.
    Holder, G. E.
    Stockman, A.
    Bhattacharya, S. S.
    Rubin, G. S.
    Yzer, S.
    van den Born, I.
    Moore, A. T.
    HUMAN GENE THERAPY, 2010, 21 (09) : 1174 - 1175
  • [44] Clinical trial of gene therapy for early onset severe retinal dystrophy resulting from defects in RPE65
    Ali, R. R.
    Bainbridge, J. W.
    Smith, A. J.
    Robbie, S.
    Fitzke, F. W.
    Holder, G. E.
    Stockman, A.
    Yzer, Z.
    Van den Born, I.
    Rubin, G. S.
    HUMAN GENE THERAPY, 2010, 21 (10) : 1393 - 1393
  • [45] Long-Term Structural Outcomes of Late-Stage RPE65 Gene Therapy
    Gardiner, Kristin L.
    Cideciyan, Artur V.
    Swider, Malgorzata
    Dufour, Valerie L.
    Sumaroka, Alexander
    Komaromy, Andras M.
    Hauswirth, William W.
    Iwabe, Simone
    Jacobson, Samuel G.
    Beltran, William A.
    Aguirre, Gustavo D.
    MOLECULAR THERAPY, 2020, 28 (01) : 266 - 278
  • [46] Gene Therapy Prevents Cone Degeneration in Two Models of Rpe65 Leber Congenital Amaurosis: rd12 and Rpe65-/-:: Rho-/- Mice
    Boye, Shannon E.
    Pang, Jijing
    Lei, Bo
    Boye, Sanford L.
    Everhart, Drew
    Umino, Yumiko
    Rohrer, Baerbel
    Chang, Bo
    Barlow, Robert
    Hauswirth, William W.
    MOLECULAR THERAPY, 2009, 17 : S288 - S289
  • [47] Glial Cell Responses and Gene Expression Dynamics in Retinas of Treated and Untreated RPE65 Mutant Dogs
    Appelbaum, Tatyana
    Santana, Evelyn
    Smith, David A.
    Beltran, William A.
    Aguirre, Gustavo D.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (12)
  • [48] Functional and structural recovery of the retina after gene therapy in the RPE65 null mutation dog
    Narfström, K
    Katz, ML
    Bragadottir, R
    Seeliger, M
    Boulanger, A
    Redmond, TM
    Caro, L
    Lai, CM
    Rakoczy, PE
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 (04) : 1663 - 1672
  • [49] The first gene therapy for RPE65 biallelic dystrophy with voretigene neparvovec-rzyl in Brazil
    Ferraz Sallum, Juliana M.
    Godoy, Juliana
    Kondo, Andrea
    Kutner, Jose Mauro
    Vasconcelos, Huber
    Maia, Andre
    OPHTHALMIC GENETICS, 2022, 43 (04) : 550 - 554
  • [50] Adaptive glial cell and gene expression alterations in retinas of treated and untreated RPE65 mutant dogs
    Appelbaum, Tatyana
    Santana, Evelyn
    Smith, David
    Beltran, William A.
    Aguirre, Gustavo D.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
12345